These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16740422)

  • 21. Transmission of Angelman syndrome by an affected mother.
    Lossie AC; Driscoll DJ
    Genet Med; 1999; 1(6):262-6. PubMed ID: 11258627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling.
    Moncla A; Malzac P; Livet MO; Voelckel MA; Mancini J; Delaroziere JC; Philip N; Mattei JF
    J Med Genet; 1999 Jul; 36(7):554-60. PubMed ID: 10424818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1031-1034delTAAC (Leu125Stop): a novel familial UBE3A mutation causing Angelman syndrome in two siblings showing distinct phenotypes.
    De Molfetta GA; Ferreira CA; Vidal DO; Giuliani Lde R; Maldonado MJ; Silva WA
    BMC Med Genet; 2012 Dec; 13():124. PubMed ID: 23256887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UBE3A gene mutations in Finnish Angelman syndrome patients detected by conformation sensitive gel electrophoresis.
    Rapakko K; Kokkonen H; Leisti J
    Am J Med Genet A; 2004 Apr; 126A(3):248-52. PubMed ID: 15054837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline mosaicism of a novel UBE3A mutation in Angelman syndrome.
    Hosoki K; Takano K; Sudo A; Tanaka S; Saitoh S
    Am J Med Genet A; 2005 Oct; 138A(2):187-9. PubMed ID: 16100729
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recurrent Angelman syndrome caused by a rare partial deletion of UBE3A gene].
    Hou Q; Shang T; Li T; Wu D; Guo Q; Chu Y; Yang Y; Liao S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 May; 36(5):491-494. PubMed ID: 31030441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of UBE3A in Angelman syndrome patients.
    Malzac P; Webber H; Moncla A; Graham JM; Kukolich M; Williams C; Pagon RA; Ramsdell LA; Kishino T; Wagstaff J
    Am J Hum Genet; 1998 Jun; 62(6):1353-60. PubMed ID: 9585605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS.
    Hitchins MP; Rickard S; Dhalla F; Fairbrother UL; de Vries BB; Winter R; Pembrey ME; Malcolm S
    Am J Med Genet A; 2004 Mar; 125A(2):167-72. PubMed ID: 14981718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angelman syndrome due to a novel splicing mutation of the UBE3A gene.
    Sartori S; Anesi L; Polli R; Toldo I; Casarin A; Drigo P; Murgia A
    J Child Neurol; 2008 Aug; 23(8):912-5. PubMed ID: 18487518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of UBE3A gene in patients referred for Angelman Syndrome.
    Tzagkaraki E; Sofocleous C; Fryssira-Kanioura H; Dinopoulos A; Goulielmos G; Mavrou A; Kitsiou-Tzeli S; Kanavakis E
    Eur J Paediatr Neurol; 2013 Jul; 17(4):366-73. PubMed ID: 23416059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parental origin and functional relevance of a de novo UBE3A variant.
    Horsthemke B; Wawrzik M; Gross S; Lich C; Sauer B; Rost I; Krasemann E; Kosyakova N; Liehr T; Weise A; Dybowski JN; Hoffmann D; Wieczorek D
    Eur J Med Genet; 2011; 54(1):19-24. PubMed ID: 20933619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing.
    Stanurova J; Neureiter A; Hiber M; de Oliveira Kessler H; Stolp K; Goetzke R; Klein D; Bankfalvi A; Klump H; Steenpass L
    Sci Rep; 2016 Aug; 6():30792. PubMed ID: 27484051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UBE3A/E6-AP mutations cause Angelman syndrome.
    Kishino T; Lalande M; Wagstaff J
    Nat Genet; 1997 Jan; 15(1):70-3. PubMed ID: 8988171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eating behavior, prenatal and postnatal growth in Angelman syndrome.
    Mertz LG; Christensen R; Vogel I; Hertz JM; Østergaard JR
    Res Dev Disabil; 2014 Nov; 35(11):2681-90. PubMed ID: 25064682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced Nociception in Angelman Syndrome Model Mice.
    McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
    J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angelman syndrome due to a termination codon mutation of the UBE3A gene.
    Al-Maawali A; Machado J; Fang P; Dupuis L; Faghfoury H; Mendoza-Londono R
    J Child Neurol; 2013 Mar; 28(3):392-5. PubMed ID: 22566713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for UBE3A gene mutations in a group of Angelman syndrome patients selected according to non-stringent clinical criteria.
    Baumer A; Balmer D; Schinzel A
    Hum Genet; 1999 Dec; 105(6):598-602. PubMed ID: 10647895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
    Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
    Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypersociability in the Angelman syndrome mouse model.
    Stoppel DC; Anderson MP
    Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and genetic analysis of two unrelated patients with Angelman syndrome and novel UBE3A mutations].
    Xu H; Ji X; Xu Y; Liu X; Zhang J; Chen Y; Xiao B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Dec; 34(6):826-830. PubMed ID: 29188609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.